Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder

European Journal of Pharmacology

Volumn 660, Issue 1, 2011, Pages 165-170

  Albayrak, Özgür ^a   Albrecht, Beate ^a   Scherag, Susann ^a   Barth, Nikolaus ^a   Hinney, Anke ^a   Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Brain derived neurotrophic factor; Dopamine; Melanocortin; Stimulant; Sympathetic nervous system; Weight reduction

Indexed keywords

GLUTAMINE; LYSINE; MELANOCORTIN 4 RECEPTOR; METHYLPHENIDATE;

ANGER; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; BODY MASS; CASE REPORT; CHILD; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC SYSTEM; DRUG DOSE INCREASE; DRUG MECHANISM; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; HUNGER; HYPERPHAGIA; IMPULSIVENESS; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; WEIGHT REDUCTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD, PRESCHOOL; HUMANS; MALE; METHYLPHENIDATE; MUTATION; OBESITY; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 79955935514     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.12.023     Document Type: Review

References (65)

1. Agranat-Meged, A., Ghanadri, Y., Eisenberg, I., Ben Neriah, Z., Kieselstein-Gross, E., Mitrani-Rosenbaum, S., 2008. Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: a newly described expression of MC4R deficiency. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 1547-1553.
2. Alvaro, J.D., Taylor, J.R., Duman, R.S., 2003. Molecular and behavioral interactions between central melanocortins and cocaine. J. Pharmacol. Exp. Ther. 304, 391-399.
3. APA, 2000. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-DSM-IV-TR. (Text Revision) 4th edition. American Psychiatric Association, Washington, DC.
4. Arnsten, A.F.T., 2006. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31, 2376-2383. (Pubitemid 44607054)
5. Arnsten, A.F., 2009. The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. J. Pediatr. 154, I-S43.
6. Altfas, J.R., 2002. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry. 13 (2), 9.
7. Baptista, T., 1999. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr. Scand. 100, 3-16.
8. Barkley, R.A., McMurray, M.B., Edelbrock, C.S., Robbins, K., 1990. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86, 184-192. (Pubitemid 20238848)
9. Bush, G., Valera, E.M., Seidman, L.J., 2005. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 57, 1273-1284. (Pubitemid 40798546)
10. Casey, B.J., Castellanos, F.X., Giedd, J.N., Marsh, W.L., Hamburger, S.D., Schubert, A.B., 1997. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36, 374-383.
11. Cone, R.D., 2005. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571-578.
12. da Silva, A.A., do Carmo, J.M., Kanyicska, B., Dubinion, J., Brandon, E., Hall, J.E., 2008. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 51, 884-890.
13. Davis, C., 2010. Attention-deficit/hyperactivity disorder: associations with overeating and obesity. Curr Psychiatry Rep. 2 (5), 389-395 (Review).
14. Doron, R., Fridman, L., Yadid, G., 2006. Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. NeuroReport 17, 1633-1636. (Pubitemid 44454771)
15. Ershov, P.V., Ugriumov, M.V., Calas, A., 2001. Quantitative evaluation of populations of neurons expressing dopamine synthesis enzymes in the arcuate nucleus neurons in developing rats. Izv. Akad. Nauk Ser. Biol. 1, 74-81.
16. Farooqi, S., O'Rahilly, S., 2006. Genetics of obesity in humans. Endocr. Rev. 27, 710-718.
17. Farooqi, I.S., Jebb, S.A., Langmack, G., Lawrence, E., Cheetham, C.H., Prentice, A.M., Hughes, I.A., McCamish, M.A., O'Rahilly, S., 1999. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884.
18. Farooqi, I.S., Matarese, G., Lord, G.M., Keogh, J.M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S.A., Perna, F., Fontana, S., Lechler, R.I., DePaoli, A.M., O'Rahilly, S., 2002. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103.
19. García-Tornadú, I., Díaz-Torga, G., Risso, G.S., Silveyra, P., Cataldi, N., Ramirez, M.C., Low, M.J., Libertun, C., Becu-Villalobos, D., 2009. Hypothalamic orexin, OX1, alphaMSH, NPY and MCRs expression in dopaminergic D2R knockout mice. Neuropeptides 43, 267-274.
20. Gray, J., Yeo, G.S., Cox, J.J., Morton, J., Adlam, A.L., Keogh, J.M., Yanovski, J.A., El Gharbawy, A., Han, J.C., Tung, Y.C., Hodges, J.R., Raymond, F.L., O'Rahilly, S., Farooqi, I.S., 2006. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366-3371. (Pubitemid 44923594)
21. Greenfield, J.R., Miller, J.W., Keogh, J.M., Henning, E., Satterwhite, J.H., Cameron, G.S., Astruc, B., Mayer, J.P., Brage, S., See, T.C., Lomas, D.J., O'Rahilly, S., Farooqi, I.S., 2009. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 44-52.
22. Hebebrand, J., Volckmar, A.L., Knoll, N., Hinney, A., 2010. Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity - but still lots to go. Obes Facts. 3 (5), 294-303.
23. Hinney, A., Hohmann, S., Geller, F., Vogel, C., Hess, C., Wermter, A.K., Brokamp, B., Goldschmidt, H., Siegfried, W., Remschmidt, H., Schäfer, H., Gudermann, T., Hebebrand, J., 2003. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J. Clin. Endocrinol. Metab. 88, 4258-4267.
24. Hinney, A., Bettecken, T., Tarnow, P., Brumm, H., Reichwald, K., Lichtner, P., Scherag, A., Nguyen, T.T., Schlumberger, P., Rief, W., Vollmert, C., Illig, T., Wichmann, H.E., Schäfer, H., Platzer, M., Biebermann, H., Meitinger, T., Hebebrand, J., 2006. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J. Clin. Endocrinol. Metab. 91, 1761-1769.
25. Hinney, A., Vogel, C.I., Hebebrand, J., 2010. From monogenic to polygenic obesity: recent advances. Eur. Child Adolesc. Psychiatry 19, 297-310.
26. Holtkamp, K., Konrad, K., Müller, B., Heussen, N., Herpertz, S., Herpertz-Dahlmann, B., Hebebrand, J., 2004. Overweight and obesity in children with Attention-Deficit/Hyperactivity Disorder. Int J Obes Relat Metab Disord. 28 (5), 685-689. (Pubitemid 38580977)
27. Humphreys, M.H., 2007. Cardiovascular and renal actions of melanocyte-stimulating hormone peptides. Curr. Opin. Nephrol. Hypertens. 16, 32-38.
28. Jaber, M., Robinson, S.W., Missale, C., Caron, M.G., 1996. Dopamine receptors and brain function. Neuropharmacology 35, 1503-1519. (Pubitemid 27026480)
29. Kernie, S.G., Liebl, D.J., Parada, L.F., 2000. BDNF regulates eating behavior and locomotor activity in mice. EMBO 19, 1290-1300. (Pubitemid 30151025)
30. Leddy, J.J., Epstein, L.H., Jaroni, J.L., Roemmich, J.N., Paluch, R.A., Goldfield, G.S., Lerman, C., 2004. Influence of methylphenidate on eating in obese men. Obes. Res. 12, 224-232.
31. Levy, L.D., Fleming, J.P., Klar, D., 2009. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int. J. Obes. 33, 326-334.
32. Liang, S.L., Pan, J.T., 2001. Potent inhibitory effect of selective D2 and D3 agonists on dopamine-responsive dorsomedial arcuate neurons in brain slices of estrogen-primed rats. Life Sci. 69, 2653-2662.
33. Licinio, J., Caglayan, S., Ozata, M., Yildiz, B.O., de Miranda, P.B., O'Kirwan, F., Whitby, R., Liang, L., Cohen, P., Bhasin, S., Krauss, R.M., Veldhuis, J.D., Wagner, A.J., DePaoli, A.M., McCann, S.M., Wong, M.L., 2004. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl Acad. Sci. USA 101, 4531-4536.
34. Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., Bergström, L., Wikberg, J.E., 2001. The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. NeuroReport 12, 2155-2158. (Pubitemid 32646263)
35. Lindblom, J., Kask, A., Hagg, E., Harmark, L., Bergstrom, L., Wikberg, J., 2002. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol. Res. 45, 119-124.
36. Lubrano-Berthelier, C., Cavazos, M., Dubern, B., Shapiro, A., Stunff, C.L., Zhang, S., Picart, F., Govaerts, C., Froguel, P., Bougneres, P., Clement, K., Vaisse, C., 2003. Molecular genetics of human obesity-associated MC4R mutations. Ann. NY Acad. Sci. 994, 49-57.
37. Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., Cone, R.D., 1994. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308.
38. National Institute for Health and Clinical Excellence, 2008. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. . (Clinical guideline 72) URL: www.nice.org.uk/CG72. Last date of access: 13.12.2010.
39. Nogueiras, R., Wiedmer, P., Perez-Tilve, D., Veyrat-Durebex, C., Keogh, J.M., Sutton, G.M., Pfluger, P.T., Castaneda, T.R., Neschen, S., Hofmann, S.M., Howles, P.N., Morgan, D.A., Benoit, S.C., Szanto, I., Schrott, B., Schürmann, A., Joost, H.G., Hammond, C., Hui, D.Y., Woods, S.C., Rahmouni, K., Butler, A.A., Farooqi, I.S., O'Rahilly, S., Rohner-Jeanrenaud, F., Tschöp, M.H., 2007. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475-3488.
40. Pagoto, S.L., Curtin, C., Lemon, S.C., Bandini, L.G., Schneider, K.L., Bodenlos, J.S., Ma, Y., 2009. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity (Silver Spring). 17 (3), 539-544.
41. Pauli-Pott, U., Albayrak, O., Hebebrand, J., Pott, W., 2010. Association between inhibitory control capacity and body weight in overweight and obese children and adolescents: dependence on age and inhibitory control component. Child Neuropsychol. 16, 592-603.
42. Poulton, A., Cowell, C.T., 2003. Slowing of growth in height and weight on stimulants: a characteristic pattern. J. Paediatr. Child Health 39, 180-185. (Pubitemid 36469915)
43. Qian, M., Johnson, A.E., Källström, L., Carrer, H., Södersten, P., 1997. Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: possible relationship to ingestive behavior. Neuroscience. 77 (4), 1077-1089. (Pubitemid 27128783)
44. Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R.M., Jaenisch, R., 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748-1757.
45. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S.C.R., Simmons, A., 1999. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry 156, 891-896. (Pubitemid 29260344)
46. Santini, F., Maffei, M., Ceccarini, G., Pelosini, C., Scartabelli, G., Rosellini, V., Chiellini, C., Marsili, A., Lisi, S., Tonacchera, M., Agretti, P., Chiovato, L., Mammoli, C., Vitti, P., Pinchera, A., 2004. Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation. J. Clin. Endocrinol. Metab. 89, 904-908.
47. Sayk, F., Heutling, D., Dodt, C., Iwen, K.A., Wellhoner, J.P., Scherag, S., Hinney, A., Hebebrand, J., Lehnert, H., 2010. Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. J. Clin. Endocrinol. Metab. 95, 1998-2002.
48. Schertz, M., Adesman, A.R., Alfieri, N.E., Bienkowski, R.S., 1996. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 98, 763-769.
49. Seidman, L.J., Valera, E.M., Makris, N., 2005. Structural brain imaging of attentiondeficit/ hyperactivity disorder. Biol. Psychiatry 57, 1263-1272. (Pubitemid 40798545)
50. Sheridan, M.A., Hinshaw, S., D'Esposito, M., 2007. Efficiency of the prefrontal cortex during working memory in attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 46, 1357-1366.
51. Sowell, E.R., Thompson, P.M., Welcome, S.E., Henkenius, A.L., Toga, A.W., Peterson, B.S., 2003. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362, 1699-1707. (Pubitemid 37468319)
52. Stahl's Essential Psychopharmacology, 2008. Neuroscientific Basis and Practical applications, Third Edition. Stephen M. Stahl. Cambridge Medicine.
53. Ste Marie, L., Miura, G.I., Marsh, D.J., Yagaloff, K., Palmiter, R.D., 2000. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. ProcNatl Acad Sci USA. 97 (22), 12339-12344.
54. Tiligada, E., Wilson, J.F., 1989. D2- but not D1-dopamine receptors are involved in the inhibitory control of alpha-melanocyte-stimulating hormone release from the rat hypothalamus. Exp. Brain Res. 74, 645-648.
55. Tsukayama, E., Toomey, S.L., Faith, M.S., Duckworth, A.L., 2010. Self-control as a protective factor against overweight status in the transition from childhood to adolescence. Arch. Pediatr. Adolesc. Med. 164, 631-635.
56. Volkow, N.D., Wang, G.J., Fowler, J.S., Gatley, S.J., Logan, J., Ding, Y.S., Hitzemann, R., Pappas, N., 1998. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155, 1325-1331. (Pubitemid 28471187)
57. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Franceschi, D., Maynard, L., Ding, Y.S., Gatley, S.J., Gifford, A., Zhu, W., Swanson, J.M., 2002. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43, 181-187. (Pubitemid 34087672)
58. Volkow, N.D., Wang, G.J., Fowler, J.S., et al., 2004. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am. J. Psychiatry 161, 1173-1180. (Pubitemid 38859165)
59. Volkow, N.D.,Wang, G.J., Newcorn, J., Telang, F., Solanto,M.V., Fowler, J.S., 2007. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 64, 932-940.
60. Voss-Andreae, A., Murphy, J.G., Ellacott, K.L., Stuart, R.C., Nillni, E.A., Cone, R.D., Fan, W., 2007. Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology 148, 1550-1560. (Pubitemid 46457101)
61. Vucetic, Z., Reyes, T.M., 2010. Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip. Rev. Syst. Biol. Med. 2, 577-593.
62. Wang, G.J., Volkow, N.D., Logan, J., Pappas, N.R., Wong, C.T., Zhu, W., Netusil, N., Fowler, J.S., 2001. Brain dopamine and obesity. Lancet 357, 354-357. (Pubitemid 32128542)
63. Waring, M.E., Lapane, K.L., 2008. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample. Pediatrics. 122 (1), e1-e6.
64. Xu, B., Goulding, E.H., Zang, K., Cepoi, D., Cone, R.D., Jones, K.R., Tecott, L.H., Reichardt, L.F., 2003. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 6, 736-742.
65. Yang, S.C., Shieh, K.R., 2005. Differential effects of melanin concentrating hormone on the central dopaminergic neurons induced by the cocaine- and amphetamine regulated transcript peptide. J. Neurochem. 92, 637-646.